Huihe

As a high-tech enterprise in the pharmaceutical and healthcare field, Beijing Century Huihe Pharmaceutical Technology Joint-stock Co., Ltd. is globally oriented and focused on the healthcare industry. It is a high-tech healthcare company covering the entire industry chain, integrating R&D, registration, production, and sales. The company continuously innovates in healthcare technology R&D, product marketing, and services, and was officially listed on the New Third Board in 2014, achieving a tremendous leap in its development.

In 2017, the company expanded into new business in the field of optometry training and rehabilitation for strabismus and amblyopia. It established a professional optometry team to study cutting-edge foreign treatment methods for strabismus and amblyopia, signed an agreement with the US company HTS to serve as the general agent in China for the VTS (Vision Therapy System) and SVI (Sanet Vision Integrator) visual function rehabilitation training systems, and set up a strabismus and amblyopia training experience store at the optometry center at its Beijing headquarters. The company has now carried out in-depth cooperation with a number of well-known ophthalmic hospitals and optometry centers in the treatment of strabismus and amblyopia. The company will continue to conduct in-depth research in the optometry field and contribute its modest efforts to the development of behavioral optometry in China.